rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ENOV
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Enovis at Jefferies Global Healthcare Conference: growth plan in focus
      Nov 17Investing.comENOVJEF
      Enovis director Angela Lalor buys $49,386 in company stock
      Nov 17Investing.comENOV
      Enovis stock price target reaffirmed at $42 by BTIG on growth
      Nov 13Investing.comENOV
      Enovis director Angela Lalor buys $50,192 in company stock
      Nov 13Investing.comENOV
      Enovis director Sharon Wienbar buys $49,917 of company stock
      Nov 11Investing.comENOV
      Enovis Stock Earnings Beat Raises Full Year Outlook
      Nov 7Yahoo FinanceENOV
      What Enovis (ENOV) Said on Its Q3 Earnings Call
      Nov 7Yahoo FinanceENOV
      Enovis Corp (ENOV) Q3 2026 Earnings Call Highlights: Organic Growth of 5%, Raised Guidance, and ...
      Nov 5Yahoo FinanceENOV
      Enovis Corporation Q3 2026 Earnings Call Summary
      Nov 5Yahoo FinanceENOV
      Enovis Q3 2026 Earnings Call Transcript
      Nov 5BenzingaENOV
      Enovis earnings beat by $0.11, revenue topped estimates
      Nov 5Investing.comENOV
      Enovis’s (NYSE:ENOV) Q3 2026 earnings results: revenue in line with expectations, stock soars
      Nov 5Yahoo FinanceENOV
      Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
      Nov 5Yahoo FinanceENOV
      Enovis: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceENOV
      Enovis Screens Cheap, But There Is A Continued M&A Overhang (NYSE:ENOV)
      Oct 24Seeking AlphaENOV
      Needham cuts Enovis stock price target on robotics deal impact
      Oct 12Investing.comENOV
      Enovis (ENOV), Why Is Fresh Attention Building Now?

      Upcoming earnings call puts Enovis in focus Enovis (ENOV) has scheduled an investor conference call and webcast for November 5, 2026 to review its third quarter results, giving shareholders fresh information on operations, profitability, and recent share performance. Recent trading has been weak for Enovis, with the share price down 31.3% over the past 90 days and 33.3% year to date, and the 1 year total shareholder return down 40.4%. This suggests sentiment has cooled despite a small 1 day...

      Oct 10Yahoo FinanceENOV
      Is Enovis (ENOV) Stock Cheap After Reaffirming 2026 Guidance?

      Enovis has seen its share price come under pressure in recent years, and that drop puts a spotlight on a simple question for investors who care about fundamentals. Do the cash flows that Enovis can generate over time line up with where the stock trades today? Over the past 5 years the share price has fallen 79.7%, which puts the focus squarely on whether the current valuation still reflects the cash the business can produce. Recent updates pointed to mid single digit organic sales growth and...

      Oct 10Yahoo FinanceENOV
      Enovis stock hits 52-week low at 17.29 USD
      Oct 8Investing.comENOV
      Analysts Offer Insights on Healthcare Companies: Trulieve Cannabis (TRLV) and Enovis (ENOV)

      Detailed price information for Enovis Corp (ENOV-N) from The Globe and Mail including charting and trades.

      Oct 6The Globe and MailENOV
      Transcript: Enovis Q2 2026 Earnings Conference Call - Enovis (NYSE:ENOV)

      Enovis (NYSE:ENOV) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time access to earnings

      Oct 6BenzingaENOV
      UBS cuts Enovis stock price target on acquisition impact
      Oct 5Investing.comENOV
      BofA Securities Adjusts Enovis Price Target to $44 From $51, Maintains Buy Rating
      Oct 5Yahoo FinanceENOV
      Insider at Medical Device Maker Buys More Than 7,500 Shares

      Motley Fool Press Release.

      Sep 14The Globe and MailENOV
      Enovis stock hits 52-week low at 18.17 USD
      Sep 11Investing.comENOV
      Wells Fargo Remains a Buy on Enovis (ENOV)

      Detailed price information for Enovis Corp (ENOV-N) from The Globe and Mail including charting and trades.

      Sep 10The Globe and MailENOV
      Enovis CAO Oliver Engert buys $50,008 in company stock
      Sep 9Investing.comENOV
      Enovis at Wells Fargo healthcare conference: robotics push takes center stage
      Sep 8Investing.comENOVWFC
      Enovis CAO Oliver Engert buys $149,970 in company stock
      Sep 5Investing.comENOV
      Enovis CEO McDonald buys $249,620 in Enov shares
      Sep 5Investing.comENOV
      Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
      Sep 4Yahoo FinanceENOV
      Enovis (ENOV) Stock Fair Value Falls As Analysts Weigh Robotics And Margin Pressure

      Enovis is back in focus for investors after a modest reset in its implied price target, with fair value in one model shifting from US$42.30 to about US$38.33. Analysts link this move to fresh thinking on the eCential Robotics acquisition, recent free cash flow trends, and the latest Q2 read through to growth plans and execution risk. As you read on, you will see how these moving parts shape the evolving Enovis story and what to watch next in the analyst narrative. Stay updated as the Fair...

      Sep 4Yahoo FinanceENOV
      What Makes Enovis (ENOV) a New Buy Stock

      Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

      Sep 3Yahoo FinanceENOV
      Enovis stock hits 52-week low at 19.12 USD
      Sep 3Investing.comENOV
      Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
      Sep 3Yahoo FinanceENOV
      Canaccord Genuity Remains a Buy on Enovis (ENOV)

      Detailed price information for Enovis Corp (ENOV-N) from The Globe and Mail including charting and trades.

      Sep 3The Globe and MailENOV
      Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition

      ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.

      Sep 2Yahoo FinanceENOV
      BMO cuts Enovis stock price target on margin headwinds from deal
      Sep 2Investing.comENOV
      Enovis Corporation (ENOV) eCential Robotics SAS - M&A Call - Slideshow (NYSE:ENOV) 2026-09-02

      2026-09-02. The following slide deck was published by Enovis Corporation in conjunction with this event.

      Sep 2Seeking AlphaENOV
      Enovis inks eCential takeover to develop surgical ortho robots

      The orthopedics specialist aims to launch a knee robot in late 2028, followed by a shoulder robot in 2029.

      Sep 2Yahoo FinanceENOV
      Citizens lowers Enovis stock price target on robotics acquisition
      Sep 2Investing.comENOV
      Enovis drops 17% on binding offer to acquire eCential Robotics (ENOV:NYSE)
      Sep 1Seeking AlphaENOV
      Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal

      Enovis (NYSE:ENOV) said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its enabling-technology capabilities and accelerate its pathway into robotic surgery. Chief Executive Officer Damien Mc

      Sep 1Yahoo FinanceENOV
      Enovis enters binding offer to acquire eCential Robotics
      Sep 1Investing.comENOV
      Enovis to acquire eCential Robotics for €155 million
      Sep 1Investing.comENOV
      Enovis to acquire eCential Robotics for up to €190 million
      Sep 1Investing.comENOV
      eCential Robotics Announces Binding Offer from Enovis
      Sep 1Financial TimesENOV
      Enovis to Acquire eCential Robotics

      Enovis (ENOV) has signed a binding offer to acquire eCential Robotics for 176 million euros ($204 mi

      Sep 1Yahoo FinanceENOV
      BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating

      Enovis (ENOV) has an average rating of buy and mean price target of $41.58, according to analysts po

      Sep 1Yahoo FinanceENOV
      Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
      Aug 31BarchartENOV

      This is the newest page. Registered accounts read further back.